Ciro Celsa
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 67
- Hepatocellular Carcinoma Treatment and Prognosis 50
- Hepatitis C virus research 12
- Liver Disease and Transplantation 9
- Epidemiology 31
- Liver Disease Diagnosis and Treatment 26
- Hepatitis B Virus Studies 7
- Co-authors
- Calogero Cammà (41 shared papers)Salvatore Petta (16 shared papers)Grazia Pennisi (13 shared papers)Giuseppe Cabibbo (31 shared papers)Marco Enea (20 shared papers)Matteo Tacelli (7 shared papers)Federica Spatola (7 shared papers)Bianca Magro (7 shared papers)
- Journals
- Journal of Hepatology (11 papers)Digestive and Liver Disease (10 papers)Liver International (7 papers)Cancers (5 papers)Hepatology (5 papers)
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Ciro Celsa
108 papers receiving 2.0k citations
Ciro Celsa's Hit Papers
Peers
Comparison fields: 5 of 79
- Hepatology 989
- Epidemiology 698
- Oncology 305
- Cancer Research 106
- Pulmonary and Respiratory Medicine 207
Countries citing papers authored by Ciro Celsa
This map shows the geographic impact of Ciro Celsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciro Celsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciro Celsa more than expected).
Fields of papers citing papers by Ciro Celsa
This network shows the impact of papers produced by Ciro Celsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciro Celsa. The network helps show where Ciro Celsa may publish in the future.
Co-authors
The 25 scholars most cited alongside Ciro Celsa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 164 | |
| 2 | Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept Hit paper breakdown → | 2023 | 142 |
| 3 | 2019 | 127 | |
| 4 | 2021 | 81 | |
| 5 | 2022 | 72 | |
| 6 | 2020 | 71 | |
| 7 | 2020 | 62 | |
| 8 | 2023 | 52 | |
| 9 | 2024 | 51 | |
| 10 | 2021 | 46 | |
| 11 | 2019 | 45 | |
| 12 | 2018 | 43 | |
| 13 | 2022 | 43 | |
| 14 | 2018 | 40 | |
| 15 | 2021 | 40 | |
| 16 | 2021 | 38 | |
| 17 | 2022 | 38 | |
| 18 | 2024 | 35 | |
| 19 | 2021 | 35 | |
| 20 | 2024 | 35 |
About Ciro Celsa
Ciro Celsa is a scholar working on Hepatology, Epidemiology, Oncology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 116 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (50 papers), Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Liver Disease and Transplantation (9 papers), Colorectal Cancer Treatments and Studies (7 papers), Hepatitis B Virus Studies (7 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Hepatology (989 citations), Epidemiology (698 citations), Oncology (305 citations), Cancer Research (106 citations) and Pulmonary and Respiratory Medicine (207 citations). Ciro Celsa has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Calogero Cammà, Salvatore Petta, Grazia Pennisi, Giuseppe Cabibbo, Marco Enea, Matteo Tacelli, Federica Spatola, Bianca Magro, Antonio Craxı̀ and Vito Di Marco. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Liver International, Cancers and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.